The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist studied in laboratory research examining incretin signaling pathways and metabolic regulatory systems.